Innocoll has secured European approval for its CollaGUARD surgical adhesion barrier for the prevention of postoperative adhesions following abdominal and pelvic surgery.

CollaGUARD is a transparent bioresorbable film of 100% type I collagen, developed using Innocoll’s proprietary CollaFilm technology.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The adhesion barrier is implanted at the time of surgery and serves as a temporary barrier to separate apposing adhesiogenic surfaces throughout the normal tissue repair process.

When tested in vivo, CollaGUARD increased the probability of remaining adhesion-free by more than six-fold, and reduced the extent and severity of adhesions.

The company also plans to seek approval in Australia, Canada, the Middle East, North Africa and south-east Asia.

It will also initiate the studies required for registration in the US.